Search Results - "Gjaltema, F"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner by Cano-Rodriguez, David, Gjaltema, Rutger A F., Jilderda, Laura J, Jellema, Pytrick, Dokter-Fokkens, Jelleke, Ruiters, Marcel H J., Rots, Marianne G

    Published in Nature communications (10-08-2016)
    “…Histone modifications reflect gene activity, but the relationship between cause and consequence of transcriptional control is heavily debated. Recent…”
    Get full text
    Journal Article
  2. 2

    CasTuner is a degron and CRISPR/Cas-based toolkit for analog tuning of endogenous gene expression by Noviello, Gemma, Gjaltema, Rutger A. F., Schulz, Edda G.

    Published in Nature communications (03-06-2023)
    “…Certain cellular processes are dose-dependent, requiring specific quantities or stoichiometries of gene products, as exemplified by haploinsufficiency and…”
    Get full text
    Journal Article
  3. 3

    Disentangling mechanisms involved in collagen pyridinoline cross-linking: The immunophilin FKBP65 is critical for dimerization of lysyl hydroxylase 2 by Gjaltema, Rutger A. F., van der Stoel, Miesje M., Boersema, Miriam, Bank, Ruud A.

    “…Collagens are subjected to extensive posttranslational modifications, such as lysine hydroxylation. Bruck syndrome (BS) is a connective tissue disorder…”
    Get full text
    Journal Article
  4. 4

    Reciprocal regulation of endothelial–mesenchymal transition by MAPK7 and EZH2 in intimal hyperplasia and coronary artery disease by Vanchin, Byambasuren, Sol, Marloes, Gjaltema, Rutger A. F., Brinker, Marja, Kiers, Bianca, Pereira, Alexandre C., Harmsen, Martin C., Moonen, Jan-Renier A. J., Krenning, Guido

    Published in Scientific reports (07-09-2021)
    “…Endothelial–mesenchymal transition (EndMT) is a form of endothelial dysfunction wherein endothelial cells acquire a mesenchymal phenotype and lose endothelial…”
    Get full text
    Journal Article
  5. 5

    Targeted epigenetic editing of SPDEF reduces mucus production in lung epithelial cells by Song, Juan, Cano-Rodriquez, David, Winkle, Melanie, Gjaltema, Rutger A F, Goubert, Désirée, Jurkowski, Tomasz P, Heijink, Irene H, Rots, Marianne G, Hylkema, Machteld N

    “…Airway mucus hypersecretion contributes to the morbidity and mortality in patients with chronic inflammatory lung diseases. Reducing mucus production is…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Advances of epigenetic editing by Gjaltema, Rutger A.F., Rots, Marianne G.

    Published in Current opinion in chemical biology (01-08-2020)
    “…Epigenetic editing refers to the locus-specific targeting of epigenetic enzymes to rewrite the local epigenetic landscape of an endogenous genomic site, often…”
    Get full text
    Journal Article
  9. 9

    Molecular insights into prolyl and lysyl hydroxylation of fibrillar collagens in health and disease by Gjaltema, Rutger A F, Bank, Ruud A

    “…Collagen is a macromolecule that has versatile roles in physiology, ranging from structural support to mediating cell signaling. Formation of mature collagen…”
    Get more information
    Journal Article
  10. 10

    Fine-Tuning the Epigenetic Landscape: Chemical Modulation of Epigenome Editors by Noviello, Gemma, Gjaltema, Rutger A F

    “…Epigenome editing has emerged as a powerful technique for targeted manipulation of the chromatin and transcriptional landscape, employing designer DNA binding…”
    Get more information
    Journal Article
  11. 11

    Procollagen Lysyl Hydroxylase 2 Expression Is Regulated by an Alternative Downstream Transforming Growth Factor β-1 Activation Mechanism by Gjaltema, Rutger A.F., de Rond, Saskia, Rots, Marianne G., Bank, Ruud A.

    Published in The Journal of biological chemistry (20-11-2015)
    “…PLOD2 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2) hydroxylates lysine residues in collagen telopeptides and is essential for collagen pyridinoline…”
    Get full text
    Journal Article
  12. 12
  13. 13

    CRISPR/dCas9 Switch Systems for Temporal Transcriptional Control by Gjaltema, Rutger A F, Schulz, Edda G

    “…In a swift revolution, CRISPR/Cas9 has reshaped the means and ease of interrogating biological questions. Particularly, mutants that result in a…”
    Get more information
    Journal Article
  14. 14

    Plasmid Delivery and Single-Cell Plasmid Expression Analysis for CRISPR/dCas9-Based Epigenetic Editing by van den Berg van Saparoea, Anna C H, van Loosen, Quint C, Sarno, Federica, Ntini, Evgenia, Rots, Marianne G, Gjaltema, Rutger A F, Verschure, Pernette J

    “…To fully exploit the potentials of reprogramming the epigenome through CRISPR/dCas9 systems for epigenetic editing, there is a growing need for improved…”
    Get more information
    Journal Article
  15. 15

    Ascorbic acid promotes a TGFβ1‐induced myofibroblast phenotype switch by Piersma, Bram, Wouters, Olaf Y., Rond, Saskia, Boersema, Miriam, Gjaltema, Rutger A. F., Bank, Ruud A.

    Published in Physiological reports (01-09-2017)
    “…l‐Ascorbic acid (AA), generally known as vitamin C, is a crucial cofactor for a variety of enzymes, including prolyl‐3‐hydroxylase (P3H), prolyl‐4‐hydroxylase…”
    Get full text
    Journal Article
  16. 16

    Ascorbic acid promotes a TGF β 1-induced myofibroblast phenotype switch by Piersma, Bram, Wouters, Olaf Y, de Rond, Saskia, Boersema, Miriam, Gjaltema, Rutger A F, Bank, Ruud A

    Published in Physiological reports (01-09-2017)
    “…l-Ascorbic acid (AA), generally known as vitamin C, is a crucial cofactor for a variety of enzymes, including prolyl-3-hydroxylase (P3H), prolyl-4-hydroxylase…”
    Get full text
    Journal Article
  17. 17

    Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22α expression in endothelial cells in response to interleukin-1β and transforming growth factor-β2 by Maleszewska, Monika, Gjaltema, Rutger A.F., Krenning, Guido, Harmsen, Martin C.

    Published in Cellular signalling (01-08-2015)
    “…Smooth muscle-22α (SM22α), encoded by transgelin (TAGLN), is expressed in mesenchymal lineage cells, including myofibroblasts and smooth muscle cells. It is an…”
    Get full text
    Journal Article
  18. 18

    A Precision Experiment to Investigate Long-Lived Radioactive Decays by Angevaare, J. R, Barrow, P, Baudis, L, Breur, P. A, Brown, A, Colijn, A. P, Cox, G, Gienal, M, Gjaltema, F, Helmling-Cornell, A, Jones, M, Kish, A, Kurz, M, Kubley, T, Lang, R. F, Massafferri, A, Perci, R, Reuter, C, Schenk, D, Schumann, M, Towers, S

    Published 08-04-2018
    “…Radioactivity is understood to be described by a Poisson process, yet some measurements of nuclear decays appear to exhibit unexpected variations. Generally,…”
    Get full text
    Journal Article
  19. 19

    P1940Reciprocal regulation of Endothelial-Mesenchymal Transition by MAPK7 and EZH2 activity in Intimal Hyperplasia and Coronary Artery Disease by Vanchin, B, Sol, M, Gjaltema, R A F, Van Der Pol, B, Brinker, M G L, Kiers, B, Pereira, A C, Harmsen, M C, Moonen, J A J, Krenning, G

    Published in European heart journal (01-10-2019)
    “…Abstract Introduction Endothelial cells play a pivotal role in the formation of neointimal lesions by the acquisition of a fibro-proliferative phenotype…”
    Get full text
    Journal Article